The Cholesterol Test Market was valued at USD 6.35 billion in 2022 and is expected to reach USD 11.58 billion in 2030 and grow at a CAGR of 7.8% over the forecast period of 2023-2030. The Driving Forces of Market Harmony: Several key factors orchestrate the market's crescendo: Rising prevalence of cardiovascular diseases: With heart disease a leading cause of mortality...

Flow Cytometry Market was estimated at USD 4,561.79 million in 2022, and from 2023 to 2030, it is anticipated to increase at a CAGR of 7.19% by 2023-30 and predicted to reach USD 7950 million by 2030. This remarkable advancement reflects the growing fascination with cellular-level insights and the vital role flow cytometry plays in: Diagnosing diseases: From cancer and...